Birth control counseling may reduce AIDS transmission in Africa, say researchers

July 26, 2012, Stanford University Medical Center

Family planning counseling could prove to be a cost-effective way to help minimize the number of children born HIV-positive in sub-Saharan Africa, a new study by School of Medicine researchers suggests.

"If you can help prevent HIV-positive women from having unplanned children, obviously you're going to prevent unnecessary ," said Clea Sarnquist, DrPH, MPH, a senior research scholar in pediatrics at Stanford and first author of the new study, which was presented today at the International AIDS Conference in Washington, D.C.

According to Sarnquist and her colleagues, about 40 percent of pregnancies in sub-Saharan Africa are unplanned. Such could be prevented if women relied on long-acting forms of — such as the intra-uterine device, or IUD, or hormonal implants — rather than birth control pills or diaphragms. Indeed, the researchers found that after receiving group counseling almost 90 percent of the HIV-positive women in the study chose a long-acting form of contraception.

The women in the study, which was conducted in a suburban region of Zimbabwe, also said they felt a greater sense of power in negotiating sexual activity, including condom use, and were more open with their partners about their HIV status, the researchers reported.

Every year, hundreds of thousands of babies are born HIV-positive in sub-Saharan Africa. While there are medications that can prevent transmission of the virus during pregnancy or breastfeeding, many of the women are unable to get them. In Zimbabwe, for instance, fewer than half of all HIV-positive women who are pregnant have access to these medications, though the numbers have been on the rise in recent years, Sarnquist said.

By contrast, studies have shown that providing counseling is more cost-effective than providing anti-AIDS medications; according to one study, annual cost savings to prevent unwanted births ranged from $26,000 in Vietnam to more than $2.2 million in South Africa. Moreover, family planning has other benefits that help improve women's overall health and well-being, Sarnquist said. For maximum prevention, both drugs and counseling should be available, she added.

In the study, Sarnquist and her colleagues worked with a group of 98 HIV-positive women in the village of Chitungwiza, about 30 miles from the Zimbabwean capital of Harare. Yvonne Maldonado, MD, professor of at Stanford and senior author of the study, has established a study site there and done research over the last two decades on preventing HIV transmission from mother to child. About 16 percent of the women in Chitungwiza are HIV-positive.

The researchers invited two-thirds of the study participants, all of whom had recently given birth, to attend three 90-minute group sessions with trained counselors. The women learned about family planning, sexual negotiation and HIV prevention and did exercises in self-esteem building and communication. The other one-third served as a control group, receiving the standard information on family planning.

The majority of the women in the region use the pill for contraception, which isn't consistently reliable as women are not always able to get to the clinic for drug refills or to afford purchasing them even if they can get there, Sarnquist said. In the sessions, the women were introduced to implants and intrauterine devices, which can protect against pregnancy for three to 10 years, depending on the device.  Fifteen nurses also were trained to install IUDs and implants, matchstick-sized cylinders that are inserted under a woman's arm and secrete hormones into the bloodstream.

Within three months, almost 90 percent of the women had opted for either the implants or IUDs, up from 13.5 percent that had used them previously, the researchers reported.
"The implants were extremely popular, which we didn't necessarily expect," Sarnquist said.
Because implants provide highly effective pregnancy prevention for four to five years, it could help women prevent unplanned pregnancies during that time. The World Health Organization recommends that women wait at least two years between pregnancies. For HIV-positive women, this spacing allows women an opportunity to maximize their own health and reduce the amount of virus in their system, which decreases the risk of passing the virus on to their unborn children, Sarnquist said.

In the study, the women were also far more inclined to talk to their partners about their HIV status, likely because of improved communication and knowledge about HIV, Sarnquist said.

"That was an unexpected finding, which does have ramifications for HIV transmission and stigma," she said.

In addition, the women in the counseling group reported feeling more power in their relationships, particularly with regard to negotiating sexual activity. For instance, more of the women felt they were able to persuade their partners to use condoms or to talk about condom use, Sarnquist said.

Sarnquist said the researchers are hoping to expand the study to a much larger population of women who could be followed over a longer period of time, with a goal of determining whether the approach can reduce the number of unplanned pregnancies, and in turn, the number of children born -positive.

The approach could be easily replicated in other regions of sub-Saharan Africa to reach many more , she said.

Researchers from the University of Zimbabwe-UCSF Collaborative Research Programme joined in conducting the study. Jennifer Kang, MPH, the former project manager, was also involved in the study.

The work was supported by U.S. President's Emergency Plan for Relief and the National Institutes of Health.

Explore further: Study in Lancet finds use of hormonal contraception doubles HIV risk

Related Stories

Study in Lancet finds use of hormonal contraception doubles HIV risk

October 3, 2011
Women using hormonal contraception --such as a birth control pill or a shot like Depo-Provera – are at double the risk of acquiring HIV, and HIV-infected women who use hormonal contraception have twice the risk of transmitting ...

Fighting HIV in South Africa should focus on couples, study finds

April 25, 2011
A new study of sexual risk behaviors within long-term couples in South Africa finds that HIV-positive people take almost as much risk in their sexual behavior when they know their partner is HIV-negative or don't know their ...

Intrauterine devices, implants most effective birth control

May 23, 2012
A study to evaluate birth control methods has found dramatic differences in their effectiveness. Women who used birth control pills, the patch or vaginal ring were 20 times more likely to have an unintended pregnancy than ...

Recommended for you

War in Ukraine has escalated HIV spread in the country: study

January 15, 2018
Conflict in Ukraine has increased the risk of HIV outbreaks throughout the country as displaced HIV-infected people move from war-affected regions to areas with higher risk of transmission, according to analysis by scientists.

Researchers offer new model for uncovering true HIV mortality rates in Zambia

January 12, 2018
A new study that seeks to better ascertain HIV mortality rates in Zambia could provide a model for improved national and regional surveillance approaches, and ultimately, more effective HIV treatment strategies.

New drug capsule may allow weekly HIV treatment

January 9, 2018
Researchers at MIT and Brigham and Women's Hospital have developed a capsule that can deliver a week's worth of HIV drugs in a single dose. This advance could make it much easier for patients to adhere to the strict schedule ...

New long-acting, less-toxic HIV drug suppresses virus in humanized mice

January 8, 2018
A team of Yale researchers tested a new chemical compound that suppresses HIV, protects immune cells, and remains effective for weeks with a single dose. In animal experiments, the compound proved to be a promising new candidate ...

Usage remains low for pill that can prevent HIV infection

January 8, 2018
From gritty neighborhoods in New York and Los Angeles to clinics in Kenya and Brazil, health workers are trying to popularize a pill that has proven highly effective in preventing HIV but which—in their view—remains woefully ...

Researchers find clues to AIDS resistance in sooty mangabey genome

January 3, 2018
Peaceful co-existence, rather than war: that's how sooty mangabeys, a monkey species found in West Africa, handle infection by SIV, a relative of HIV, and avoid developing AIDS-like disease.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.